Health product recall

Zerbaxa (2020-12-16)

Starting date:
December 16, 2020
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type I
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-74593

Last updated: 2020-12-17

Summary

  • Product: Zerbaxa

Reason

Product sterility may be compromised in affected lots

Depth of distribution

Wholesalers, Retailers, Healthcare establishments, Healthcare practitioners

Affected products

Zerbaxa

DIN, NPN, DIN-HIM

DIN 02446901

Dosage form

Powder For Solution

Strength

Ceftolozane (Ceftolozane Sulfate) 1 G / VIAL
Tazobactam (Tazobactam Sodium) 0.5 G / VIAL

Lot or serial number

SP1561A
SP1617A
SP1637A

Companies

Recalling Firm
Merck Canada Inc.
16750 Transcanada Hwy
Kirkland
H9H 4M7
Quebec
CANADA
Marketing Authorization Holder
Merck Canada Inc.
16750 Transcanada Hwy
Kirkland
H9H 4M7
Quebec
CANADA

Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Date modified: